Parkinson's disease, Medtronic and US FDA

US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.
FDA OKs First Adaptive DBS System for Parkinson’s Disease
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized neuromodulation that responds to the patient’s changing needs.
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency.
Medtronic's deep brain stimulation system for Parkinson's disease wins FDA nod
Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease. The approval is for BrainSense Adaptive deep brain stimulation (DBS)and BrainSense Electrode Identifier.
Medtronic Parkinson's Disease Brain Stimulation System Gets FDA Approval
Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.
Medtronic gains FDA OK for self-adjusting DBS system for Parkinson’s
The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement personalizes therapy based on a patient’s brain activity in real-time. Therapy automatically adjusts, which minimizes the need for patients to manually change the level of stimulation to control symptoms.
FDA approves Medtronic’s adaptive technology for Parkinson’s
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
FDA Approves Medtronic’s BrainSense Adaptive Deep Brain Stimulation for Parkinson Disease
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real-time brain activity to improve Parkinson disease symptom control without manual adjustments.
Parkinson’s Patients Have a New Way to Manage Their Symptoms
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
Studies of Parkinson’s disease have long overlooked Pacific populations – our work shows why that must change
New research shows people in specific Polynesian communities have a much higher rate of a form of Parkinson’s disease ...
Parkinson's centre a one-stop-shop of support for those with the neurological disease
Parkinson Wellness Projects’ 5,000-square-foot centre at Blanshard and Hillside offers everything from exercise programs to ...
TheHealthSite.com on MSN2d
Jerry Butler, Legendary Soul Singer 'The Iceman,' Dies at 85 After Long Battle With Parkinson's Disease
Legendary soul singer Jerry Butler, known as "The Iceman," has passed away at 85, leaving behind an unforgettable legacy in ...
The Spun on MSN6h
Former NFL Quarterback Dead From Parkinson's at 74
A former NFL quarterback has passed away at 74 years old, following a battle with Parkinson's disease and prostate cancer.
manilatimes16h
Piding Pidi enables artist with Parkinson's Disease in NCCA Gallery Exhibit
SHOWCASING a 20-year collection of art, Elmer Nocheseda unveiled his lifelong works at the National Commission for Culture ...
Hosted on MSN1d
Indoor cycling event raises money to help those battling Parkinson's disease
An archeologist from over 150 years ago sent a message to the future which has just been uncovered during a more detailed dig. Ukraine's President Volodymyr Zelenskiy said on Sunday (February 23) he ...
Knowridge1d
Cholesterol may play a key role in Parkinson’s disease
Scientists in China have discovered a cholesterol-related compound that may contribute to the development of Parkinson’s disease. This compound, called 24-OHC, appears to help spread harmful protein ...